2m 2m 2m 2m 2m 2m 2m
Merck (MRK)
NYSE
$127.11-$3.09 (-2.38%)
Price as of Aug 03, 2026 6:57 PM EDT- $320.6BMarket Cap
- 69.70%1-Year Change
- Drug Manufacturers - GeneralIndustry
Merck (MRK)
$127.11-$3.09 (-2.38%)
MRK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $130.20 | ||
Change | +$0.41 (+0.32%) | ||
Open | $128.92 | ||
High | $131.04 | ||
Low | $128.14 | ||
Previous Close | $129.79 | ||
Volume | 7,738,763 | ||
30-Day Average Volume | 8,654,057 | ||
1-Week Change | -0.66% | ||
1-Month Change | 1.32% | ||
1-Year Change | 69.70% | ||
3-Year Change | 33.90% | ||
5-Year Change | 97.97% | ||
Fundamentals | |||
Shares Outstanding | 2.5B | ||
Total Assets | $128.7B | ||
Market Cap | $320.6B | ||
Enterprise Value | $364.3B | ||
Period: QTR TTM FY | |||
Revenue | $16.3B | ||
Net Income | -$4.2B | ||
Free Cash Flow | $2.9B | ||
EBIT | -$3.5B | ||
EBITDA | -$3.0B | ||
Net Working Capital | $8.1B | ||
EPS | -$1.72 | ||
Enterprise Value/EBITDA | -124 | ||
Enterprise Value/Revenue | 22 | ||
P/B | 7 | ||
P/E | -76 | ||
PEG | 0 | ||
Price/Free Cash Flow | 110 | ||
Price/Operating Cash Flow | 82 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.61% | ||
Trailing Annual Dividend Yield | 2.58% | ||
Ex-Dividend Date | 09/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield